Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Tivic Health Q4 & FY 2025 Earnings Call - Full Pivot to TLR5 Immunotherapy with In-House Manufacturing
Tivic used 2025 to execute a decisive strategic pivot, exiting its consumer device business and concentrating solely on a TLR5 immunotherapy platform anchored by lead candidate Entolimod and next-gene...
- Tivic completed a strategic pivot in 2025, exiting the ClearUP device and suspending non-core neuromodulation programs to focus 100% on biotherapeutics based on a TLR5 platform.
- Lead assets are Entolimod and a next-generation candidate, Entolasta, positioned to protect bone marrow and GI tissue from radiation and chemotherapy damage, according to management.
- Management claims Entolimod can be used prophylactically and post-exposure, addressing both hematopoietic and gastrointestinal injury, differentiating it from current G-CSF therapies.
- +12 more takeaways
Winnebago Industries Second Quarter Fiscal 2026 Earnings Call - Motorhome Momentum Offsets Towable and Marine Softness, Guidance Intact
Winnebago delivered a cautious but constructive quarter. Consolidated revenue rose 6% year over year, driven by a 29% surge in the motorhome segment that more than offset a 9% decline in towables and ...
- Consolidated net revenues rose 6% year over year in Q2 fiscal 2026, led by the motorhome segment.
- Motorhome RV revenue jumped 29% in the quarter, driving volume leverage and a 270 basis point improvement in segment operating margin to 2.4% for Q2.
- Towable RV revenue declined 9%, pressured by a shift toward lower price point models and lower unit volumes, though selective pricing helped offset some pressure.
- +12 more takeaways
Elemental Royalty Corporation Q4 2025 Earnings Call - Merger and Tether backing turbocharge cash flow and introduce XAUT dividend
The newly merged Elemental Royalty reported a record year driven by the combination of Elemental, Altus and EMX. Pro forma 2025 revenue would have been about $87.2 million, adjusted EBITDA was $35 mil...
- Merger impact: The combination of Elemental, Altus and EMX materially enlarged the royalty base and cash flow profile, with pro forma 2025 revenue of about $87.2 million if merged on January 1.
- Record financials: Adjusted EBITDA of $35 million and operating cash flow of $34 million for the reported period, with management highlighting continued leverage as full-year GEOs run through the combined vehicle next year.
- Tether strategic investor: Tether and Tether Investments invested $100 million, now owning about 32% of the company, enabling Elemental to offer the first dividend option payable in XAUT (Tether gold token).
- +12 more takeaways
Epsilon Energy Year-End 2025 Earnings Call - Peak acquisition and Parkman development set the stage for multi-year production and EBITDA growth
Epsilon reported a banner 2025, with Adjusted EBITDA up 75% and production up 54% year-over-year, driven by development activity and the November closing of the Peak Companies acquisition. The deal im...
- Adjusted EBITDA rose 75% and total production increased 54% year-over-year in 2025.
- Epsilon closed the Peak Companies acquisition on November 14, 2025, adding Powder River Basin (PRB) assets, a local operating team, and over 100 net high-IRR drilling locations.
- Proved developed producing reserves grew 69% and total proved reserves increased 86% year-over-year, with total company reserves at 156 Bcfe, including ~78 Bcf from the PRB deal.
- +12 more takeaways
Paychex Q3 Fiscal 2026 Earnings Call - Paycor and AI Drive Acceleration, Q4 Flagged for Timing Headwinds
Paychex posted a strong Q3, with revenue up 20% to $1.8 billion and adjusted operating income up 22%, led by the Paycor acquisition and rapid deployment of AI capabilities. Management Solutions grew 2...
- Revenue grew 20% year over year to $1.8 billion in Q3 fiscal 2026, driven by the Paycor acquisition and organic momentum.
- Adjusted operating income rose 22% year over year; adjusted operating margin expanded about 80 basis points to 47.7% for the quarter.
- Management Solutions revenue increased 23% to $1.4 billion; Paycor accounted for roughly 19 percentage points of headline growth.
- +12 more takeaways
Cintas Corporation Fiscal 2026 Q3 Earnings Call - Record Revenues, All-time Margins and UniFirst Deal Advances
Cintas delivered a clean quarter: record revenue of $2.84 billion (total growth 8.9%, organic 8.2%), all-time high gross margins across its route businesses and an EPS beat that prompted a raise to fi...
- Q3 revenue a record $2.84 billion, up 8.9% year over year, with organic growth of 8.2%.
- Gross margin expanded to 51.0%, a 40 basis point increase; all-time high gross margins reported across the three route-based businesses and First Aid and Safety.
- Operating income rose to $659.9 million, up 8.2% year over year; adjusted growth would be 11% after removing a prior-year one-time gain.
- +13 more takeaways
Ondas Inc. Q4 2025 Earnings Call - M&A-fueled pivot to multi-domain ISR lifts 2026 revenue target to at least $375M
Ondas used the Q4 report to declare a transformation from a narrow autonomous-systems seller into a multi-domain, software-defined ISR platform, driven heavily by acquisitions and strategic partnershi...
- Q4 revenue $30.1 million, up 629% year-over-year and nearly 200% sequentially, driven by Ondas Autonomous Systems deliveries.
- Full-year 2025 revenue $50.7 million, up 605% from 2024, with full-year gross margin improving to 40% from 5% the prior year.
- Company raised 2026 revenue guidance to at least $375 million, more than doubling its January outlook and reflecting contribution from recent acquisitions.
- +12 more takeaways
Cognyte Q4 FY2026 Earnings Call - Double-digit revenue growth, record gross margins and $448M FY2027 guide
Cognyte closed FY2026 with healthy top-line momentum, margin expansion and clearer visibility into the next 12 months. Q4 revenue was $106.2 million, up 12.4% year-over-year, and full-year revenue rea...
- Q4 revenue $106.2 million, up 12.4% year-over-year; FY2026 revenue $400.0 million, up 14.1% year-over-year.
- Q4 non-GAAP gross margin reached a record 74.7%; full-year non-GAAP gross margin was 73%, achieving the FY2028 margin target two years early.
- Q4 non-GAAP operating income doubled year-over-year to $12.1 million; full-year non-GAAP operating income was $36.7 million and GAAP operating income turned positive at $13.3 million (from a loss prior year).
- +12 more takeaways
Enlivex Q4 2025 Earnings Call - Treasury gains from RAIN prediction-market token drive $1.23B net income
Enlivex reported a startling shift in 2025: $1.23 billion in net income and $25.48 of diluted EPS, driven not by product sales but by marked-to-market gains in a prediction-markets focused treasury. M...
- Enlivex reported full-year 2025 net income of $1.23 billion and diluted EPS of $25.48, results driven by valuation gains in treasury and treasury-related assets, not operating biotech revenues.
- Total treasury and treasury-related assets ended 2025 at $2.31 billion, and shareholders equity was $1.93 billion, reflecting mark-to-market appreciation of digital holdings.
- Company frames a dual-engine model, combining a clinical-stage biological program (Allocetra) with a prediction-markets-focused digital treasury, arguing the two are complementary.
- +12 more takeaways
Worthington Enterprises Q3 FY2026 Earnings Call - 24% Revenue Surge, 14% Organic Growth and Multi-Year Data Center Upside
Worthington delivered a take-no-prisoners quarter: total revenue jumped 24% to $379 million, driven by 14% organic growth and $32 million from recent acquisitions, while adjusted EBITDA rose to $85 mi...
- Revenue jumped 24% year over year to $379 million, driven by 14% organic growth and $32 million from acquisitions in Q3.
- GAAP EPS was $0.92 versus $0.79 a year ago; adjusted EPS was $0.98, up from $0.91, marking the sixth consecutive quarter of year-over-year adjusted EPS growth.
- Adjusted EBITDA rose to $85 million from $74 million, with an adjusted EBITDA margin of about 22.3%; trailing twelve-month adjusted EBITDA is $297 million, up $54 million year over year.
- +12 more takeaways